Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen

New York, NY – April 2, 2025 – Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”) proudly hosted Dr. Quan-Yang Duh, a world-renowned endocrine surgeon and Chief of Endocrine Surgery at the University of California, San Francisco (UCSF), for an in-depth clinical observation visit in Guangzhou and Shenzhen, China. During his visit, Dr. Duh closely examined the real-world application of Baird Medical’s advanced microwave ablation (MWA) technology.

In Guangzhou, Dr. Duh visited several prestigious hospitals, where he observed a range of thyroid ablation cases. One particularly notable case involved a patient with bilateral thyroid nodules, including a 4 cm lesion, successfully treated using Baird Medical’s MWA system. The procedure, performed by Dr. Feng Han, a leading MWA specialist at Sun Yat-sen University Cancer Center, was executed with remarkable precision and efficiency. The patient remained fully awake and comfortable throughout, underscoring the minimally invasive nature of the procedure.

“The case was highly educational,” said Dr. Duh. “Dr. Han demonstrated exceptional expertise, and the speed and accuracy of the procedure highlight both the skill of the medical team and the medical team and the sophistication of the technology.” Following the procedure, Dr. Duh engaged in in-depth academic discussions with Dr. Feng Han and Dr. Jian Hua Zhou, Chief of Interventional Radiology at Sun Yat-sen University Cancer Center, further fostering international collaboration in thyroid ablation advancements.

Dr. Duh continued his visit in Shenzhen, where he observed additional MWA procedures at one of the city’s leading thyroid hospitals. He also participated in academic discussions with top specialists in the field and delivered a presentation titled “Advances in Surgical Management of Thyroid and Parathyroid Diseases.” His talk provided valuable insights into the latest developments in endocrine surgery and facilitated an in-depth exchange on the growing role of microwave ablation in thyroid treatment, particularly its integration with surgical approaches.

“We are honored to facilitate these global academic exchanges and showcase the clinical impact of our MWA technology,” said Haimei Wu, Chairwoman of Baird Medical. “As we continue to expand, we remain committed to driving innovation and working alongside top-tier medical professionals to enhance the accessibility and precision of minimally invasive thyroid treatments.”

As Baird Medical continues its global expansion, the Company remains dedicated to pioneering advancements in microwave ablation technology and forging strategic partnerships that redefine the future of thyroid care.